Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 1998

Enbrel(Etanercept)Amgen Inc. logoAMGN

Medicare prescription drug cost, prescriptions and prescribers, 2024 · made by Amgen Inc.

$632.3M

Medicare cost, 2024

Medicare drug plans spent $632.3 million on Enbrel (etanercept) in 2024, for 80,775 prescriptions and refills filled by 10,535 patients. It ranks 82nd among all drugs by Medicare drug plan spending. At about $7,828 per prescription it is a high-cost drug. California accounts for the most spending ($66.8 million, 11% of the total).

Medicare cost, 2024

$632.3M

+0.9% from 2023

Prescriptions

81K

$7,827.79 per claim

Patients

11K

7,008 prescribers

Total spending, 2024

$632.8M

$60,025.75 per patient

Questions and answers

How much does Medicare spend on Enbrel?

Medicare prescription drug plans paid $632.3M for Enbrel in 2024, for 80,775 prescriptions and refills to 10,535 patients (up 0.9% from 2023). The average cost per claim was $7,827.79.

Which state spends the most on Enbrel?

California had the highest Medicare cost for Enbrel in 2024: $66.8M for 10,024 claims, followed by New York ($46.6M).

Who prescribes Enbrel the most?

Michael Babilonia Roman, internal medicine in Mayaguez, PR, had the highest Medicare cost for Enbrel in 2024: 340 claims costing $2.5M.

Who makes Enbrel?

Enbrel is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Amgen.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Enbrel was $632.8M in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Enbrel, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Michael Babilonia Roman Mayaguez, PRInternal Medicine34030$2.5M
Elvin R Garcia McAllen, TXRheumatology19523$1.6M
Jolanta Sobotka-Czarnecki Flint, MIRheumatology19921$1.5M
Richard B Gremillion Millcreek, UTRheumatology17118$1.4M
Kenneth B Wiesner Sacramento, CARheumatology14918$1.2M
John Vischio Glastonbury, CTInternal Medicine11613$1.0M
James E Dowd Brighton, MIRheumatology12114$992K
William W Mullins North Bethesda, MDRheumatology6411$976K
Roberto D Alvarez Aibonito, PRRheumatology12621$937K
Grace A Makhlouf Sugar Land, TXRheumatology11013$893K
Steven A Portney Bingham Farms, MIRheumatology11712$853K
Don L Stromquist Murray, UTRheumatology9412$824K
James E Gore Nashville, TNRheumatology11312$815K
Victoria Katz Brooklyn, NYRheumatology11028$783K
David A Campbell Fort Wayne, INRheumatology96Under 11$780K
Linda M Atkinson Baldwin Park, CAInternal Medicine15721$765K
Juan M Rodriguez Bayamon, PRRheumatology9312$688K
Khalid M Syed Lynn, MARheumatology8012$687K
1790785160 Rheumatology89Under 11$673K
Sohrab Fallahi Montgomery, ALRheumatology8713$670K
Leroy A Pacheco Albuquerque, NMRheumatology72Under 11$668K
Monika Mohan Okemos, MIRheumatology9015$657K
Robert W Shurmur Battle Creek, MIRheumatology79Under 11$646K
Brian J Keroack Portland, MERheumatology8211$645K
Gwendolyn Kane-Wanger Waban, MAInternal Medicine76Under 11$629K

Prescriber data by year

YearPrescribersClaimsPatientsCost
20227,21485,24811,304$611.6M
20237,03381,91710,670$626.9M
20247,00880,77510,535$632.3M

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
AmgenAMGN logoAMGN80,845$632.8M

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
14
RxNorm concept IDs
1653223, 1653225, 2182338, 2182340, 2392140
Application numbers
BLA103795

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube